Company intelligence / Profile preview
Sairiyo Therapeutics
Toronto, Ontario, Canadamarketscreener.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Sairiyo Therapeutics specializes in repurposing and reformulating established natural medicines to improve their clinical utility, focusing on serious infectious diseases and oncology indications. Its lead program PD‑001—a patented enteric-coated oral formulation of cepharanthine—has demonstrated improved bioavailability over generic versions in animal models and has entered the regulatory process for a first-in-human Phase 1 trial targeting viral infectious disease and cancer applications. The company also explores psychedelic compounds for non-neuropsychiatric uses at an early R&D stage.
- Therapeutic areas
- OncologyImmunologyPsychiatryNeurologyInfectious Diseases
- Modalities
- Small molecules (notably reformulated natural products such as cepharanthine)Psychedelics (R&D stage)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Parent companies provide funding, expertise, development support. No major external pharma partnerships disclosed.
Beyond the preview
Go deeper on Sairiyo Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sairiyo Therapeutics.